Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis.

ABSTRACT:

Background

Clinical evidence suggests that pregnant women are more vulnerable to COVID-19, since they are at increased risk for disease progression and for obstetric complications, such as premature labor, miscarriage, preeclampsia, cesarean delivery, fetal growth restriction and perinatal death. Despite this evidence, pregnant women are often excluded from clinical trials, resulting in limited knowledge on COVID-19 management. The aim of this systematic review and meta-analysis is to provide better evidence on the efficacy and safety of available COVID-19 treatment in pregnant women.

Methods

Four authors searched major electronic databases from inception until 1 st November-2022 for controlled trials/observational studies, investigating outcomes after the administration of

SUBMITTER: Di Gennaro F 

PROVIDER: S-EPMC10634005 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature